Skip to content 
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California. more
| Time Frame | VIVS | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -18.3% | 0.14% | 0.86% |
| 1-Month Return | -4.95% | -0.72% | -0.47% |
| 3-Month Return | -16.88% | 3.7% | 1.34% |
| 6-Month Return | 7.87% | 19.92% | 8.86% |
| 1-Year Return | -54.29% | 7% | 14.32% |
| 3-Year Return | -92.49% | 16.96% | 67.75% |
| 5-Year Return | -99.26% | 34.22% | 77.15% |
| 10-Year Return | -99.59% | 145.99% | 279.46% |
| Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | - | 1.50M | 370.00K | 109.00K | 144.00K | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":24.67,"profit":true},{"date":"2024-03-31","value":7.27,"profit":true},{"date":"2025-03-31","value":9.6,"profit":true}] |
| Cost of Revenue | - | - | - | - | 5.00K | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}] |
| Gross Profit | - | 1.50M | 370.00K | 109.00K | 139.00K | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":24.67,"profit":true},{"date":"2024-03-31","value":7.27,"profit":true},{"date":"2025-03-31","value":9.27,"profit":true}] |
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 96.53% | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":96.53,"profit":true}] |
| Operating Expenses | 16.83M | 12.98M | 18.10M | 15.20M | 12.76M | [{"date":"2021-03-31","value":92.96,"profit":true},{"date":"2022-03-31","value":71.7,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":83.95,"profit":true},{"date":"2025-03-31","value":70.47,"profit":true}] |
| Operating Income | (16.83M) | (11.48M) | (17.73M) | (15.09M) | (12.62M) | [{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1147900000,"profit":false},{"date":"2023-03-31","value":-1773100000,"profit":false},{"date":"2024-03-31","value":-1508600000,"profit":false},{"date":"2025-03-31","value":-1261600000,"profit":false}] |
| Total Non-Operating Income/Expense | 17.00K | 41.00K | 928.00K | 822.00K | 10.26M | [{"date":"2021-03-31","value":0.17,"profit":true},{"date":"2022-03-31","value":0.4,"profit":true},{"date":"2023-03-31","value":9.04,"profit":true},{"date":"2024-03-31","value":8.01,"profit":true},{"date":"2025-03-31","value":100,"profit":true}] |
| Pre-Tax Income | (16.82M) | (11.45M) | (17.26M) | (14.67M) | (2.49M) | [{"date":"2021-03-31","value":-1682400000,"profit":false},{"date":"2022-03-31","value":-1144600000,"profit":false},{"date":"2023-03-31","value":-1725700000,"profit":false},{"date":"2024-03-31","value":-1466900000,"profit":false},{"date":"2025-03-31","value":-248600000,"profit":false}] |
| Income Taxes | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | [{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true}] |
| Income After Taxes | (16.83M) | (11.45M) | (17.26M) | (14.67M) | (2.49M) | [{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}] |
| Income From Continuous Operations | (16.83M) | (11.45M) | (17.26M) | (14.67M) | (2.49M) | [{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}] |
| Net Income | (16.83M) | (11.45M) | (17.26M) | (14.67M) | (2.49M) | [{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}] |
| EPS (Diluted) | (3.11) | (1.25) | (11.39) | (17.52) | (2.51) | [{"date":"2021-03-31","value":-311,"profit":false},{"date":"2022-03-31","value":-125,"profit":false},{"date":"2023-03-31","value":-1138.83,"profit":false},{"date":"2024-03-31","value":-1752,"profit":false},{"date":"2025-03-31","value":-251,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| VIVS | |
|---|---|
| Cash Ratio | 2.73 |
| Current Ratio | 3.10 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| VIVS | |
|---|---|
| ROA (LTM) | -75.10% |
| ROE (LTM) | -35.31% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| VIVS | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.27 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.73 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| VIVS | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 35.75 |
| P/B | 0.47 |
| Price/FCF | NM |
| EV/R | 39.56 |
| EV/Ebitda | NM |
VivoSim Labs, Inc. (VIVS) share price today is $1.89
Yes, Indians can buy shares of VivoSim Labs, Inc. (VIVS) on Vested. To buy
Yes, you can purchase fractional shares of VivoSim Labs, Inc. (VIVS) via the Vested app. You can start investing in VivoSim Labs, Inc. (VIVS) with a minimum investment of $1.
You can invest in shares of VivoSim Labs, Inc. (VIVS) via Vested in three simple steps:
The 52-week high price of VivoSim Labs, Inc. (VIVS) is $21.96. The 52-week low price of VivoSim Labs, Inc. (VIVS) is $1.41.
The price-to-earnings (P/E) ratio of VivoSim Labs, Inc. (VIVS) is
The price-to-book (P/B) ratio of VivoSim Labs, Inc. (VIVS) is 0.47
The dividend yield of VivoSim Labs, Inc. (VIVS) is 0.00%
The market capitalization of VivoSim Labs, Inc. (VIVS) is $5.01M
The stock symbol (or ticker) of VivoSim Labs, Inc. is VIVS
Consider the share price of VivoSim Labs, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether VivoSim Labs, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in VivoSim Labs, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the VivoSim Labs, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of VivoSim Labs, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that VivoSim Labs, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
